March 17, 2008
Onyvax European Phase IIB Clinical Trial Completes Enrolment

January 14, 2008
Onyvax, UCL and LGC Awarded Grant For a £1.8m Project to Develop Predictive Manufacturing Tools for Cell Based Cancer Vaccines

December 4, 2007
Onyvax Granted Broad US Patent for Lead Prostate Cancer Vaccine

September 26, 2007
Phase IIb clinical trial of Onyvax-P
in early stage prostate cancer initiated in United States

December 11, 2006
Onyvax Phase IIb Clinical Trial of Prostate Cancer Vaccine Underway with the Addition of UK Clinical Centres - Trial Adopted by the UK National Cancer Research Network

November 15, 2006
Vaccine Stimulates Immune System to Fight Cancer

May 8, 2006
Onyvax Raises £8 Million to Advance Development of Prostate Cancer Vaccine

April 3, 2006
Eden Biodesign and Onyvax Limited Announce Biomanufacturing Contract

March 27, 2006
University Of Michigan Researchers Zero-In On CD55